13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q3 2024. See the latest, Q3 2026 →

Reported value

$2.95B

+1.2% on the quarter before

Positions

75

33 new, 22 sold out

Top 10

62.6%

of the value

Est. gain

+$224.2M

on stocks held all quarter

Est. return

+12.7%

on those stocks since Q2 2024

Filed

Nov 14, 2024

On SEC EDGAR ↗

Positions as of Sep 30, 2024, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2024. Striped tiles are options.

51 others18%
Natera Inc15%
Coupang Inc9.7%
Coherent Corp9.0%
Woodward Inc6.1%
Seagate Technology Hldngs Pl6.1%
Philip Morris Intl Inc4.7%
SPDR Ser Tr3.9%
MercadoLibre3.3%Freeport-McMoRan2.3%
Flutter Entmt Plc2.1%
Kinder Morgan2.0%
Philip Morris Intl Inc1.9%
Teck Resources Ltd1.8%
Vistra1.6%Broadcom1.4%
Discover Finl Svcs1.4%
Ascendis Pharma A/S1.3%
Mid-Amer Apt Cmntys Inc1.3%
Camden Ppty Tr1.2%
Daktronics Inc1.1%
Wabtec1.1%
Nvent Electric Plc1.1%
Seagate Technology Hldngs Pl1.0%
Banco Macro Sa0.9%

Largest buys

Since Q2 2024, sized at quarter-end prices.

  1. Natera Inc~$202.1MAdded, 7.3% → 15.3% of the portfolio+1,591,970 shares
  2. SPDR Ser Tr~$116.2MNew, 0.0% → 3.9% of the portfolio+2,053,323 shares
  3. Broadcom~$41.4MNew, 0.0% → 1.4% of the portfolio+239,980 shares
  4. Ascendis Pharma A/S~$39.6MNew, 0.0% → 1.3% of the portfolio+265,040 shares
  5. Nvent Electric Plc~$31.7MNew, 0.0% → 1.1% of the portfolio+451,065 shares
  6. Philip Morris Intl Inc~$29.8MAdded, 3.1% → 4.7% of the portfolio+245,280 shares
  7. Seagate Technology Hldngs PlCALL~$28.8MNew, 0.0% → 1.0% of the portfolio+263,000 underlying
  8. Teva Pharmaceutical Inds Ltd~$25.7MNew, 0.0% → 0.9% of the portfolio+1,427,950 shares
  9. MercadoLibre~$23.8MAdded, 2.1% → 3.3% of the portfolio+11,617 shares
  10. United States Stl Corp~$23.4MNew, 0.0% → 0.8% of the portfolio+663,090 shares

Largest sells

Since Q2 2024, sized at quarter-end prices.

  1. Vistra~$264.8MCut, 7.7% → 1.6% of the portfolio−2,233,876 shares
  2. Microsoft~$153.8MCut, 6.1% → 0.6% of the portfolio−357,395 shares
  3. Kinder Morgan~$91.5MCut, 4.6% → 2.0% of the portfolio−4,141,165 shares
  4. GE Vernova~$68.3MCut, 1.7% → 0.3% of the portfolio−267,818 shares
  5. Mid-Amer Apt Cmntys Inc~$64.4MCut, 3.1% → 1.3% of the portfolio−405,470 shares
  6. Philip Morris Intl IncCALL~$59.6MCut, 3.3% → 1.9% of the portfolio−490,800 underlying
  7. Coherent Corp~$54.3MCut, 8.9% → 9.0% of the portfolio−611,010 shares
  8. Option Care Health Inc~$51.8MSold out, 1.8% → 0.0% of the portfolio−1,871,818 shares
  9. ZoomInfo~$38.6MCut, 2.6% → 0.7% of the portfolio−3,741,180 shares
  10. Flex Ltd~$36.8MCut, 1.5% → 0.4% of the portfolio−1,100,255 shares

Holdings

As of Sep 30, 2024; changes in shares since Jun 30, 2024.

Positions, sorted by share of the portfolio
HoldingValue
Natera IncCOM · shares +81% · price +17.2%15.3%$452.8M+$36.9M
Coupang IncCL A · shares +6.6% · price +17.2%9.7%$287.1M+$39.5M
Coherent CorpCOM · shares −17% · price +22.7%9.0%$264.8M+$49.0M
Woodward IncCOM · shares +11% · price −1.6%6.1%$181.4M−$2.7M
Seagate Technology Hldngs PlORD SHS · shares −6.5% · price +6.1%6.1%$179.7M+$10.3M
Philip Morris Intl IncCOM · shares +28% · price +19.8%4.7%$137.7M+$17.8M
SPDR Ser TrS&P REGL BKG · shares New3.9%$116.2M—
MercadoLibreCOM · shares +32% · price +24.9%3.3%$98.7M+$14.9M
Freeport-McMoRanCL B · shares +19% · price +2.7%2.3%$68.7M+$1.5M
Flutter Entmt PlcSHS · shares −22% · price +29.8%2.1%$61.8M+$14.2M
Kinder MorganCOM · shares −61% · price +11.2%2.0%$57.7M+$5.8M
Philip Morris Intl IncCALLCOM · shares −51%1.9%$57.3M—
Teck Resources LtdCL B · shares −30% · price +9.1%1.8%$53.1M+$4.4M
VistraCOM · shares −85% · price +37.9%1.6%$46.4M+$12.7M
BroadcomCOM · shares New1.4%$41.4M—
Discover Finl SvcsCOM · shares +70% · price +7.2%1.4%$40.0M+$1.6M
Ascendis Pharma A/SSPONSORED ADR · shares New1.3%$39.6M—
Mid-Amer Apt Cmntys IncCOM · shares −63% · price +11.4%1.3%$37.9M+$3.9M
Camden Ppty TrSH BEN INT · shares −50% · price +13.2%1.2%$35.9M+$4.2M
Daktronics IncCOM · shares +3.0% · price −7.5%1.1%$33.2M−$2.6M
WabtecCOM · shares +19% · price +15.0%1.1%$32.7M+$3.6M
Nvent Electric PlcSHS · shares New1.1%$31.7M—
Seagate Technology Hldngs PlCALLORD SHS · shares New0.98%$28.8M—
Banco Macro SaSPON ADR B · shares +55% · price +10.8%0.91%$26.9M+$1.7M
Teva Pharmaceutical Inds LtdSPONSORED ADS · shares New0.87%$25.7M—
Total 75 positions100%$2.95B+$224.2M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2024 to Q3 2024: 41 stocks held throughout, up $224.2M (+12.7%).

  1. Coherent Corp+$49.0M+23%
  2. Coupang Inc+$39.5M+17%
  3. Natera Inc+$36.9M+17%
  4. Philip Morris Intl Inc+$17.8M+20%
  5. MercadoLibre+$14.9M+25%
  6. Adobe−$1.3M−7%
  7. Daktronics Inc−$2.6M−7%
  8. Woodward Inc−$2.7M−2%
  9. Springworks Therapeutics Inc−$4.0M−15%
  10. ZoomInfo−$5.2M−19%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free